Selection of T cells reactive against autologous B lymphoblastoid cells during chronic rheumatoid arthritis. NLM AIDSLINE Important note: Information in this article was accurate in 1997. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Selection of T cells reactive against autologous B lymphoblastoid cells during chronic rheumatoid arthritis.

J Immunol. 1996 Nov 15;157(10):4697-706. Unique Identifier : AIDSLINE MED/97064232
David-Ameline J; Lim A; Davodeau F; Peyrat MA; Berthelot JM; Semana G; Pannetier C; Gaschet J; Vie H; Even J; Bonneville M; INSERM Unit 211, Institute of Biology, Nantes, France.


Abstract: The repertoire and Ag specificity of T cells infiltrating inflamed joints from a chronic rheumatoid arthritis (RA) patient were studied in detail. Repertoire analysis demonstrated a reduced clonality of joint-infiltrating lymphocytes (JIL) as compared with patient's PBL, which was presumably due to an intra-articular expansion of T cell clones with recurrent TCR features. Strikingly, a large fraction of these JIL T cell clones, which were predominantly CD8+, proliferated in vitro when exposed to autologous B lymphoblastoid cells (BLC), unlike randomly chosen PBL clones derived from the same patient. This proliferative response was HLA-restricted, which confirmed a classical TCR-mediated recognition of BLC and was not observed against autologous PHA blasts, suggesting recognition of either EBV or B cell-specific Ags. Finally, a preliminary analysis of synovial lymphocytes derived from another chronic RA patient demonstrated a similar enrichment for T cells reactive against autologous BLC within JILs as compared with patient's PBLs. Taken together, these results, which suggest frequent expansions of autologous BLC-reactive T cells within inflamed joints of chronic RA patients, provide a basis for future studies evaluating the fine specificity and pathogenicity of these lymphocytes.
Keywords: Adult Arthritis, Rheumatoid/*IMMUNOLOGY/*PATHOLOGY B-Lymphocytes/*IMMUNOLOGY Cell Separation Chronic Disease Clone Cells CD8-Positive T-Lymphocytes/IMMUNOLOGY Female Flow Cytometry Human Joints *Lymphocyte Transformation Multigene Family/IMMUNOLOGY Receptors, Antigen, T-Cell, alpha-beta/IMMUNOLOGY Stem Cells/*IMMUNOLOGY Support, Non-U.S. Gov't T-Lymphocyte Subsets/*IMMUNOLOGY JOURNAL ARTICLEKWDadultarthritis,rheumatoid/KWDimmunology/KWDpathologyb-lymphocytes/KWDimmunologycellseparationchronicdiseaseclonecellscd8-positivet-lymphocytes/immunologyfemaleflowcytometryhumanjointsKWDlymphocytetransformationmultigenefamily/immunologyreceptors,antigen,t-cell,alpha-beta/immunologystemcells/KWDimmunologysupport,non-uKWDsKWDgov'tt-lymphocytesubsets/KWDimmunologyjournalarticle
970228
M9721857

Copyright © 1997 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1997. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1997. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .